Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Cash from Financing Activities (2016 - 2020)

Glucotrack's Cash from Financing Activities history spans 7 years, with the latest figure at $13.0 million for Q1 2020.

  • For the quarter ending Q1 2020, Cash from Financing Activities rose 1620.51% year-over-year to $13.0 million, compared with a TTM value of $13.0 million through Dec 2020, up 209.89%, and an annual FY2025 reading of $17.0 million, up 24.01% over the prior year.
  • Cash from Financing Activities for Q1 2020 was $13.0 million at Glucotrack, up from -$574.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $13.0 million in Q1 2020, with the low at -$574.0 in Q4 2019.
  • Average Cash from Financing Activities over 5 years is $2.2 million, with a median of $853845.0 recorded in 2017.
  • Year-over-year, Cash from Financing Activities soared 14332.58% in 2016 and then plummeted 100.22% in 2019.
  • Tracing GCTK's Cash from Financing Activities over 5 years: stood at $757885.0 in 2016, then tumbled by 50.3% to $376662.0 in 2017, then crashed by 32.03% to $256034.0 in 2018, then plummeted by 100.22% to -$574.0 in 2019, then skyrocketed by 2266476.31% to $13.0 million in 2020.
  • Per Business Quant, the three most recent readings for GCTK's Cash from Financing Activities are $13.0 million (Q1 2020), -$574.0 (Q4 2019), and $3.4 million (Q2 2019).